Luskin M, Lane A
Haematologica. 2023; 109(1):44-52.
PMID: 36951152
PMC: 10772502.
DOI: 10.3324/haematol.2022.282171.
Hosseininejad-Chafi M, Alirahimi E, Ramezani B, Oghalaie A, Sotoudeh N, Ghaderi H
Iran J Basic Med Sci. 2022; 25(1):27-31.
PMID: 35656448
PMC: 9118281.
DOI: 10.22038/IJBMS.2021.54293.12195.
Sanz L, Ibanez-Perez R, Guerrero-Ochoa P, Lacadena J, Anel A
Biomedicines. 2021; 9(11).
PMID: 34829955
PMC: 8615520.
DOI: 10.3390/biomedicines9111729.
Kreitman R, Pastan I
Biomolecules. 2021; 11(11).
PMID: 34827694
PMC: 8615697.
DOI: 10.3390/biom11111696.
Pemmaraju N, Konopleva M
Blood Adv. 2020; 4(16):4020-4027.
PMID: 32841341
PMC: 7448601.
DOI: 10.1182/bloodadvances.2019000173.
Bacterial Toxins for Cancer Therapy.
Zahaf N, Schmidt G
Toxins (Basel). 2017; 9(8).
PMID: 28788054
PMC: 5577570.
DOI: 10.3390/toxins9080236.
Targeted diphtheria toxin to treat BPDCN.
Fitzgerald D
Blood. 2014; 124(3):310-2.
PMID: 25035145
PMC: 4102704.
DOI: 10.1182/blood-2014-06-578633.
Immunotoxins: the role of the toxin.
Antignani A, Fitzgerald D
Toxins (Basel). 2013; 5(8):1486-502.
PMID: 23965432
PMC: 3760048.
DOI: 10.3390/toxins5081486.
Receptor-mediated uptake of an extracellular Bcl-x(L) fusion protein inhibits apoptosis.
Liu X, Castelli J, Youle R
Proc Natl Acad Sci U S A. 1999; 96(17):9563-7.
PMID: 10449732
PMC: 22248.
DOI: 10.1073/pnas.96.17.9563.
Abrogation of the non-specific toxicity of abrin conjugated to anti-lymphocyte globulin.
Thorpe P, Cumber A, Williams N, EDWARDS D, Ross W, Davies A
Clin Exp Immunol. 1981; 43(1):195-200.
PMID: 7249392
PMC: 1537133.
The effect of abrin, anti-lymphocyte globulin and their conjugates on the immune response of mice to sheep red blood cells.
EDWARDS D, Smith A, Ross W, Cumber A, Thorpe P, Davies A
Experientia. 1981; 37(3):256-7.
PMID: 7238778
DOI: 10.1007/BF01991641.
Anti-Thy 1.2 monoclonal antibody linked to ricin is a potent cell-type-specific toxin.
Youle R, Neville Jr D
Proc Natl Acad Sci U S A. 1980; 77(9):5483-6.
PMID: 6968914
PMC: 350085.
DOI: 10.1073/pnas.77.9.5483.
Antibody-directed cytotoxic agents: use of monoclonal antibody to direct the action of toxin A chains to colorectal carcinoma cells.
Gilliland D, Steplewski Z, Collier R, Mitchell K, Chang T, KOPROWSKI H
Proc Natl Acad Sci U S A. 1980; 77(8):4539-43.
PMID: 6933502
PMC: 349879.
DOI: 10.1073/pnas.77.8.4539.
Antibody-targeted liposomes: increase in specific toxicity of methotrexate-gamma-aspartate.
Heath T, Montgomery J, Piper J, Papahadjopoulos D
Proc Natl Acad Sci U S A. 1983; 80(5):1377-81.
PMID: 6572395
PMC: 393600.
DOI: 10.1073/pnas.80.5.1377.
LDL-mediated targeting of liposomes to leukemic lymphocytes in vitro.
Vidal M, Sainte-Marie J, Philippot J, Bienvenue A
EMBO J. 1985; 4(10):2461-7.
PMID: 4054094
PMC: 554530.
DOI: 10.1002/j.1460-2075.1985.tb03957.x.
Cloning and expression in Escherichia coli of three fragments of diphtheria toxin truncated within fragment B.
Bishai W, Miyanohara A, Murphy J
J Bacteriol. 1987; 169(4):1554-63.
PMID: 3549695
PMC: 211982.
DOI: 10.1128/jb.169.4.1554-1563.1987.
Antibody-mediated targeting in the treatment and diagnosis of cancer: an overview.
Ford C, Casson A
Cancer Chemother Pharmacol. 1986; 17(3):197-208.
PMID: 3527466
DOI: 10.1007/BF00256685.
High-level expression of a proteolytically sensitive diphtheria toxin fragment in Escherichia coli.
Bishai W, Rappuoli R, Murphy J
J Bacteriol. 1987; 169(11):5140-51.
PMID: 3312166
PMC: 213919.
DOI: 10.1128/jb.169.11.5140-5151.1987.
The First Bagshawe lecture. Towards generating cytotoxic agents at cancer sites.
Bagshawe K
Br J Cancer. 1989; 60(3):275-81.
PMID: 2675955
PMC: 2247184.
DOI: 10.1038/bjc.1989.270.
Chimeric toxins: toxic, disulfide-linked conjugate of concanavalin A with fragment A from diphtheria toxin.
Gilliland D, Collier R, Moehring J, Moehring T
Proc Natl Acad Sci U S A. 1978; 75(11):5319-23.
PMID: 281682
PMC: 392954.
DOI: 10.1073/pnas.75.11.5319.
